Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Population-Based Estimate of Melioidosis, Kenya.

Muthumbi EM, Gordon NC, Mochamah G, Nyongesa S, Odipo E, Mwarumba S, Mturi N, Etyang AO, Dance DAB, Scott JAG, Morpeth SC.

Emerg Infect Dis. 2019 May;25(5):984-987. doi: 10.3201/eid2505.180545.

2.

The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.

Williams PCM, Waichungo J, Gordon NC, Sharland M, Murunga S, Kamau A, Berkley JA.

J Med Microbiol. 2019 May;68(5):711-719. doi: 10.1099/jmm.0.000973. Epub 2019 Apr 17.

PMID:
30994430
3.

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.

Thwaites GE, Scarborough M, Szubert A, Saramago Goncalves P, Soares M, Bostock J, Nsutebu E, Tilley R, Cunningham R, Greig J, Wyllie SA, Wilson P, Auckland C, Cairns J, Ward D, Lal P, Guleri A, Jenkins N, Sutton J, Wiselka M, Armando GR, Graham C, Chadwick PR, Barlow G, Gordon NC, Young B, Meisner S, McWhinney P, Price DA, Harvey D, Nayar D, Jeyaratnam D, Planche T, Minton J, Hudson F, Hopkins S, Williams J, Török ME, Llewelyn MJ, Edgeworth JD, Walker AS.

Health Technol Assess. 2018 Oct;22(59):1-148. doi: 10.3310/hta22590.

4.

Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care.

Nambiar K, Seifert H, Rieg S, Kern WV, Scarborough M, Gordon NC, Kim HB, Song KH, Tilley R, Gott H, Liao CH, Edgeworth J, Nsutebu E, López-Cortés LE, Morata L, Walker AS, Thwaites G, Llewelyn MJ, Kaasch AJ; International Staphylococcus aureus collaboration (ISAC) study group (with linked authorship to members in the Acknowledgements) and the ESCMID Study Group for Bloodstream Infections and Sepsis (ESGBIS).

J Infect. 2018 Dec;77(6):516-525. doi: 10.1016/j.jinf.2018.08.015. Epub 2018 Sep 1.

PMID:
30179645
5.

Accuracy of Different Bioinformatics Methods in Detecting Antibiotic Resistance and Virulence Factors from Staphylococcus aureus Whole-Genome Sequences.

Mason A, Foster D, Bradley P, Golubchik T, Doumith M, Gordon NC, Pichon B, Iqbal Z, Staves P, Crook D, Walker AS, Kearns A, Peto T.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e01815-17. doi: 10.1128/JCM.01815-17. Print 2018 Sep.

6.

Robust Prediction of Resistance to Trimethoprim in Staphylococcus aureus.

Fowler PW, Cole K, Gordon NC, Kearns AM, Llewelyn MJ, Peto TEA, Crook DW, Walker AS.

Cell Chem Biol. 2018 Mar 15;25(3):339-349.e4. doi: 10.1016/j.chembiol.2017.12.009. Epub 2018 Jan 4.

7.

Severe infections emerge from commensal bacteria by adaptive evolution.

Young BC, Wu CH, Gordon NC, Cole K, Price JR, Liu E, Sheppard AE, Perera S, Charlesworth J, Golubchik T, Iqbal Z, Bowden R, Massey RC, Paul J, Crook DW, Peto TE, Walker AS, Llewelyn MJ, Wyllie DH, Wilson DJ.

Elife. 2017 Dec 19;6. pii: e30637. doi: 10.7554/eLife.30637.

8.

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

Thwaites GE, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J, Wyllie SA, Wilson P, Auckland C, Cairns J, Ward D, Lal P, Guleri A, Jenkins N, Sutton J, Wiselka M, Armando GR, Graham C, Chadwick PR, Barlow G, Gordon NC, Young B, Meisner S, McWhinney P, Price DA, Harvey D, Nayar D, Jeyaratnam D, Planche T, Minton J, Hudson F, Hopkins S, Williams J, Török ME, Llewelyn MJ, Edgeworth JD, Walker AS; United Kingdom Clinical Infection Research Group (UKCIRG).

Lancet. 2018 Feb 17;391(10121):668-678. doi: 10.1016/S0140-6736(17)32456-X. Epub 2017 Dec 14.

9.

AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS).

Seale AC, Gordon NC, Islam J, Peacock SJ, Scott JAG.

Wellcome Open Res. 2017 Sep 26;2:92. doi: 10.12688/wellcomeopenres.12527.1. eCollection 2017.

10.

African Americans in Oral and Maxillofacial Surgery: Factors Affecting Career Choice, Satisfaction, and Practice Patterns.

Criddle TR, Gordon NC, Blakey G, Bell RB.

J Oral Maxillofac Surg. 2017 Dec;75(12):2489-2496. doi: 10.1016/j.joms.2017.08.012. Epub 2017 Aug 12.

PMID:
28886356
11.

Whole-Genome Sequencing Reveals the Contribution of Long-Term Carriers in Staphylococcus aureus Outbreak Investigation.

Gordon NC, Pichon B, Golubchik T, Wilson DJ, Paul J, Blanc DS, Cole K, Collins J, Cortes N, Cubbon M, Gould FK, Jenks PJ, Llewelyn M, Nash JQ, Orendi JM, Paranthaman K, Price JR, Senn L, Thomas HL, Wyllie S, Crook DW, Peto TEA, Walker AS, Kearns AM.

J Clin Microbiol. 2017 Jul;55(7):2188-2197. doi: 10.1128/JCM.00363-17. Epub 2017 May 3.

12.

Identifying lineage effects when controlling for population structure improves power in bacterial association studies.

Earle SG, Wu CH, Charlesworth J, Stoesser N, Gordon NC, Walker TM, Spencer CCA, Iqbal Z, Clifton DA, Hopkins KL, Woodford N, Smith EG, Ismail N, Llewelyn MJ, Peto TE, Crook DW, McVean G, Walker AS, Wilson DJ.

Nat Microbiol. 2016 Apr 4;1:16041. doi: 10.1038/nmicrobiol.2016.41.

13.

Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2016 Apr 20;7:11465. doi: 10.1038/ncomms11465. No abstract available.

14.

The Stealthy Superbug: the Role of Asymptomatic Enteric Carriage in Maintaining a Long-Term Hospital Outbreak of ST228 Methicillin-Resistant Staphylococcus aureus.

Senn L, Clerc O, Zanetti G, Basset P, Prod'hom G, Gordon NC, Sheppard AE, Crook DW, James R, Thorpe HA, Feil EJ, Blanc DS.

MBio. 2016 Jan 19;7(1):e02039-15. doi: 10.1128/mBio.02039-15.

15.

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2015 Dec 21;6:10063. doi: 10.1038/ncomms10063. Erratum in: Nat Commun. 2016;7:11465.

16.

Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13.

Urbach C, Gordon NC, Strickland I, Lowne D, Joberty-Candotti C, May R, Herath A, Hijnen D, Thijs JL, Bruijnzeel-Koomen CA, Minter RR, Hollfelder F, Jermutus L.

Chem Biol. 2015 Nov 19;22(11):1442-1452. doi: 10.1016/j.chembiol.2015.09.013. Epub 2015 Nov 5.

17.

Whole-genome sequencing in hierarchy with pulsed-field gel electrophoresis: the utility of this approach to establish possible sources of MRSA cross-transmission.

Moore G, Cookson B, Gordon NC, Jackson R, Kearns A, Singleton J, Smyth D, Wilson AP.

J Hosp Infect. 2015 May;90(1):38-45. doi: 10.1016/j.jhin.2014.12.014. Epub 2015 Jan 13.

PMID:
25648940
18.

Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing.

Gordon NC, Price JR, Cole K, Everitt R, Morgan M, Finney J, Kearns AM, Pichon B, Young B, Wilson DJ, Llewelyn MJ, Paul J, Peto TE, Crook DW, Walker AS, Golubchik T.

J Clin Microbiol. 2014 Apr;52(4):1182-91. doi: 10.1128/JCM.03117-13. Epub 2014 Feb 5.

19.

The usefulness of whole genome sequencing in the management of Staphylococcus aureus infections.

Price J, Gordon NC, Crook D, Llewelyn M, Paul J.

Clin Microbiol Infect. 2013 Sep;19(9):784-9. doi: 10.1111/1469-0691.12109. Epub 2013 Jan 18. Review.

20.

A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance.

Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, Ip CL, Wilson DJ, Didelot X, O'Connor L, Lay R, Buck D, Kearns AM, Shaw A, Paul J, Wilcox MH, Donnelly PJ, Peto TE, Walker AS, Crook DW.

BMJ Open. 2012 Jun 6;2(3). pii: e001124. doi: 10.1136/bmjopen-2012-001124. Print 2012.

21.

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.

Wareham DW, Gordon NC, Hornsey M.

J Antimicrob Chemother. 2011 May;66(5):1047-51. doi: 10.1093/jac/dkr069. Epub 2011 Mar 8.

PMID:
21393131
22.

Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii.

Wareham DW, Gordon NC.

J Clin Pathol. 2011 Feb;64(2):164-7. doi: 10.1136/jcp.2010.083469. Epub 2010 Dec 3.

PMID:
21131630
23.

Two new variants of and creation of a repository for Stenotrophomonas maltophilia quinolone protection protein (Smqnr) genes.

Wareham DW, Gordon NC, Shimizu K.

Int J Antimicrob Agents. 2011 Jan;37(1):89-90. doi: 10.1016/j.ijantimicag.2010.10.002. Epub 2010 Nov 18. No abstract available.

PMID:
21093222
24.

Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.

Gordon NC, Png K, Wareham DW.

Antimicrob Agents Chemother. 2010 Dec;54(12):5316-22. doi: 10.1128/AAC.00922-10. Epub 2010 Sep 27.

25.

Allele-specific polymerase chain reaction (PCR) for rapid detection of the aac(6')-Ib-cr quinolone resistance gene.

Wareham DW, Umoren I, Khanna P, Gordon NC.

Int J Antimicrob Agents. 2010 Nov;36(5):476-7. doi: 10.1016/j.ijantimicag.2010.07.012. Epub 2010 Sep 16. No abstract available.

PMID:
20843664
26.

Polymicrobial necrotizing fasciitis involving enterobacteria producing CTX-M-15 extended-spectrum β-lactamases.

Soleimanian S, Gordon NC, Wareham DW.

J Med Microbiol. 2011 Jan;60(Pt 1):135-7. doi: 10.1099/jmm.0.021998-0. Epub 2010 Sep 2.

PMID:
20813849
27.

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.

Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K, Livermore DM, Woodford N.

J Antimicrob Chemother. 2010 Aug;65(8):1589-93. doi: 10.1093/jac/dkq218. Epub 2010 Jun 16.

PMID:
20554571
28.

Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.

Gordon NC, Wareham DW.

Int J Antimicrob Agents. 2010 Aug;36(2):129-31. doi: 10.1016/j.ijantimicag.2010.03.025. Epub 2010 May 15.

PMID:
20472404
29.

Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia.

Gordon NC, Wareham DW.

J Antimicrob Chemother. 2010 Mar;65(3):483-9. doi: 10.1093/jac/dkp476. Epub 2010 Jan 12.

PMID:
20071366
30.

Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance.

Gordon NC, Wareham DW.

Int J Antimicrob Agents. 2010 Mar;35(3):219-26. doi: 10.1016/j.ijantimicag.2009.10.024. Epub 2010 Jan 4. Review.

PMID:
20047818
31.

Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display.

Gordon NC, Lien S, Johnson J, Wallweber HJ, Tran T, Currell B, Mathieu M, Quan C, Starovasnik MA, Hymowitz SG, Kelley RF.

J Mol Biol. 2010 Feb 12;396(1):166-77. doi: 10.1016/j.jmb.2009.11.041. Epub 2009 Nov 26.

PMID:
19945466
32.

Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia.

Gordon NC, Wareham DW.

J Clin Microbiol. 2009 Sep;47(9):3024-5. doi: 10.1128/JCM.01033-09. Epub 2009 Jul 29.

33.
34.

Reduced susceptibility of multidrug-resistant Acinetobacter baumannii to tigecycline in combination with 1-(1-naphthylmethyl)-piperazine is not a pH-dependent phenomenon.

Wareham DW, Gordon NC, Casals JB, Bean DC.

J Antimicrob Chemother. 2009 May;63(5):1075-6. doi: 10.1093/jac/dkp072. Epub 2009 Mar 11. No abstract available.

PMID:
19279048
35.

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline.

Gordon NC, Wareham DW.

J Antimicrob Chemother. 2009 Apr;63(4):775-80. doi: 10.1093/jac/dkn555. Epub 2009 Jan 21.

PMID:
19158109
36.

A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.

Gear RW, Gordon NC, Hossaini-Zadeh M, Lee JS, Miaskowski C, Paul SM, Levine JD.

J Pain. 2008 Apr;9(4):337-41. doi: 10.1016/j.jpain.2007.11.011. Epub 2008 Jan 16.

37.

Management of head and neck infections in the immunocompromised patient.

Gordon NC, Connelly S.

Oral Maxillofac Surg Clin North Am. 2003 Feb;15(1):103-10. No abstract available.

PMID:
18088664
38.

Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.

Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, DeForge LE, Martin F, Starovasnik MA, Fuh G.

Blood. 2006 Nov 1;108(9):3103-11. Epub 2006 Jul 13.

39.

Neuroleptics antagonize nalbuphine antianalgesia.

Gear RW, Lee JS, Miaskowski C, Gordon NC, Paul SM, Levine JD.

J Pain. 2006 Mar;7(3):187-91.

PMID:
16516824
40.

Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.

Hymowitz SG, Patel DR, Wallweber HJ, Runyon S, Yan M, Yin J, Shriver SK, Gordon NC, Pan B, Skelton NJ, Kelley RF, Starovasnik MA.

J Biol Chem. 2005 Feb 25;280(8):7218-27. Epub 2004 Nov 12.

41.

Engineering an APRIL-specific B cell maturation antigen.

Patel DR, Wallweber HJ, Yin J, Shriver SK, Marsters SA, Gordon NC, Starovasnik MA, Kelley RF.

J Biol Chem. 2004 Apr 16;279(16):16727-35. Epub 2004 Feb 4.

42.

Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.

Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, Levine JD.

Neurosci Lett. 2003 Nov 6;351(1):5-8. Erratum in: Neurosci Lett. 2012 Sep 13;525(2):184.

PMID:
14550900
43.

BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.

Gordon NC, Pan B, Hymowitz SG, Yin J, Kelley RF, Cochran AG, Yan M, Dixit VM, Fairbrother WJ, Starovasnik MA.

Biochemistry. 2003 May 27;42(20):5977-83.

PMID:
12755599
44.

Sexual dimorphism in very low dose nalbuphine postoperative analgesia.

Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, Levine JD.

Neurosci Lett. 2003 Mar 13;339(1):1-4.

PMID:
12618286
45.

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM.

Immunity. 2002 Oct;17(4):515-24.

46.

The PYRIN domain: a member of the death domain-fold superfamily.

Fairbrother WJ, Gordon NC, Humke EW, O'Rourke KM, Starovasnik MA, Yin JP, Dixit VM.

Protein Sci. 2001 Sep;10(9):1911-8.

48.

Soft tissue surgery in the oral and maxillofacial region.

Smith RA, Karas N, Pogrel MA, Gordon NC, Goldman K, Silva R, Whalen M.

J Calif Dent Assoc. 2000 Sep;28(9):668-80.

PMID:
11324048
50.

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.

Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD.

Pain. 1999 Nov;83(2):339-45.

PMID:
10534607

Supplemental Content

Loading ...
Support Center